Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Using cidofovir cream for a rare skin disease can cause skin darkening.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

The new delivery system could improve pain and inflammation relief in gout.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Tofacitinib is effective and safe for treating alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Combining systemic and topical treatments effectively cured a dog's skin condition.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The compound 4c showed strong potential as an anticancer agent.

A Shih Tzu with Cushing syndrome developed skin issues and was euthanized after treatment led to neurological problems.

Steroids, infection management, and nutritional support can significantly improve symptoms of Cronkhite-Canada Syndrome.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

PPX causes much less hair loss than traditional taxanes.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.